Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice

Citation
Cc. Niemeyer et al., Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice, INT J CANC, 81(4), 1999, pp. 588-591
Citations number
20
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF CANCER
ISSN journal
00207136 → ACNP
Volume
81
Issue
4
Year of publication
1999
Pages
588 - 591
Database
ISI
SICI code
0020-7136(19990517)81:4<588:PMTMCA>2.0.ZU;2-1
Abstract
Amphiregulin (Ar) and Cripto (Cr) are autocrine growth factors for mammary cells and both have been observed to exhibit high expression in human mamma ry tumors, in contrast with adjacent tissues. To investigate whether Ar and Cr play roles in the progression of mammary cell proliferation to unregula ted growth and tumor formation, the levels of expression were examined in t ransgenic mice (TGM) that over-express several different oncogenes: MMTV-Po lyoma virus middle T antigen (MMTV-PyMT), MMTV-c-ErbB2 (c-neu, HER2) and MT -hTGF alpha. These transgenic mice all produce mammary tumors but with diff erent rates of progression. The levels of Ar were induced up to 10-fold in association with hyperplasia in 2 of the TGM. Cr overexpression was consist ently observed in hyperplastic mammary glands in all the animal models, dec reasing in overt tumors in 2 of the TGM models. In MMTV-PyMT mammary glands , the levels of Cr expression rose 7- to 10-fold in hyperplastic tissue and 25-fold the levels in tumors compared to age-matched transgene negative mi ce. Ar and especially Cr thus should have potential value as markers of pre neoplastic change in mammary tissue. (C) 1999 Wiley-Liss, Inc.